98%
921
2 minutes
20
The thioredoxin (Trx) system, found universally, is responsible for the regeneration of reversibly oxidized protein thiols in living cells. This system is made up of a Trx and a Trx reductase, and it plays a central role in maintaining thiol-based redox homeostasis by reducing oxidized protein thiols, such as disulfide bonds in proteins. Some Trxs also possess a chaperone function that is independent of thiol-disulfide exchange, in addition to their thiol-disulfide reductase activity. These two activities of the Trx system are involved in numerous physiological processes in bacteria. This review describes the diverse physiological roles of the Trx system that have emerged throughout bacterial evolution. The Trx system is essential for responding to oxidative and nitrosative stress. Beyond this primary function, the Trx system also participates in redox regulation and signal transduction, and in controlling metabolism, motility, biofilm formation, and virulence. This range of functions has evolved alongside the diversity of bacterial lifestyles and their specific constraints. This evolution can be characterized by the multiplication of the systems and by the specialization of cofactors or targets to adapt to the constraints of atypical lifestyles, such as photosynthesis, insect endosymbiosis, or spore-forming bacteria.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/1462-2920.16668 | DOI Listing |
Redox Biol
August 2025
Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address:
Carbapenem- and colistin-resistant Gram-negative bacteria have become one of the most severe public health issues worldwide. The development of advanced antibacterial agents that can outpace microbial adaptation is imperative. The thioredoxin (Trx) and glutaredoxin (Grx) systems play important roles in maintaining redox homeostasis within Gram-negative bacterial cell membranes, with thioredoxin reductase (TrxR) and glutathione reductase (GR) being classical antibacterial targets.
View Article and Find Full Text PDFBiomed Pharmacother
August 2025
Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia, with pancreatic β-cell dysfunction and oxidative stress playing central roles in its pathogenesis. Recent studies have identified disulfidptosis as a novel form of regulated cell death driven by disulfide stress,a condition marked by abnormal intracellular disulfide accumulation and NADPH/NADP+ imbalance. This process is particularly prominent in glucose-deprived cells with high expression of the cystine transporter SLC7A11, where impaired disulfide reduction leads to cytoskeletal collapse and cell death.
View Article and Find Full Text PDFAntioxidants (Basel)
August 2025
Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, Immunology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.
Reactive oxygen species (ROS) act as double-edged swords in cancer biology-facilitating tumor growth, survival, and metastasis at moderate levels while inducing oxidative damage and cell death when exceeding cellular buffering capacity. To survive under chronic oxidative stress, cancer cells rely on robust antioxidant systems such as the glutathione (GSH) and thioredoxin (Trx), and superoxide dismutases (SODs). These systems maintain redox homeostasis and sustain ROS-sensitive signaling pathways including MAPK/ERK, PI3K/Akt/mTOR, NF-κB, STAT3, and HIF-1α.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
August 2025
Cardiac Investigation Unit, Auckland City Hospital, Auckland, New Zealand.
Background: DESyne BDS Plus represents a novel triple drug therapy (TRx) applied on a coronary stent platform eluting the antiproliferative drug Sirolimus along with two anticoagulants (Rivaroxaban and Argatroban) to reduce the site-specific thrombotic risk.
Aims: To assess the feasibility and safety of this novel device against a contemporary drug-eluting stent.
Methods: This prospective, multicenter randomized (1:1) trial included 202 patients assigned between the device group (DESyne BDS Plus) and the control group (DESyne X2).
Int J Biol Macromol
September 2025
Department of Biotechnology & Bioengineering, School of Biosciences & Technology, Galgotias University, Greater Noida, Uttar Pradesh 203201, India.
The purpose of this review is to explore the role of the thioredoxin (TRX)/TRX-interacting protein (TXNIP)/microRNAs (miRs) network in neuronal cells and the function of TXNIP-targeted miRs in regulating neuroinflammation, neuronal apoptosis, and mitochondria dysfunction in Parkinson's disease (PD). The high TXNIP level activates apoptosis signal-regulating kinase-1 (ASK-1) and trigger a signaling cascade involving the phosphorylation of c-Jun-N-terminal kinase (JNK) and mitogen-activated protein kinase (p38 MAPK). The activation of these kinases contributes to the misfolding and aggregation of α-synuclein, a hallmark of PD.
View Article and Find Full Text PDF